Cargando…

38227 Specific and highly potent human monoclonal antibodies against SARS-CoV-2

ABSTRACT IMPACT: We devised a new method to produce highly potent SARS-CoV2-specific that can be used to treat severely ill patients with Covid-19. OBJECTIVES/GOALS: Neutralizing antibodies against SARS-CoV-2 are thought to offer the most immediate and effective treatment for those severely afflicte...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Mattos Barbosa, Mayara Garcia, Liu, Hui, Huynh, Daniel, Platt, Jeffrey L., Cascalho, Marilia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Basic Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827835/ http://dx.doi.org/10.1017/cts.2021.459

Ejemplares similares

IgV somatic mutation of human anti–SARS-CoV-2 monoclonal antibodies governs neutralization and breadth of reactivity
por: de Mattos Barbosa, Mayara Garcia, et al.
Publicado: (2021)

Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis
por: Zupancic, Jennifer M., et al.
Publicado: (2021)

Discovery and characterization of high-affinity, potent SARS-CoV-2 neutralizing antibodies via single B cell screening
por: Schardt, John S., et al.
Publicado: (2021)

Double lock of a potent human therapeutic monoclonal antibody against SARS-CoV-2
por: Zhu, Ling, et al.
Publicado: (2020)

IgM in the Kidney: A Multiple Personality Disorder
por: Platt, Jeffrey L., et al.
Publicado: (2015)

Cell Fusion in Malignancy: A Cause or Consequence? A Provocateur or Cure?
por: Platt, Jeffrey L., et al.
Publicado: (2019)

Challenges and potentials of xenotransplantation
por: Cascalho, Marilia, et al.
Publicado: (2008)

TNFRSF13B Diversification Fueled by B Cell Responses to Environmental Challenges—A Hypothesis
por: Cascalho, Marilia, et al.
Publicado: (2021)

TNFRSF13B in B cell responses to organ transplantation
por: Cascalho, Marilia, et al.
Publicado: (2023)

Potent mouse monoclonal antibodies that block SARS-CoV-2 infection
por: Guo, Youjia, et al.
Publicado: (2021)

Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD
por: Ma, Hang, et al.
Publicado: (2022)

Establishment of a monoclonal antibody against a peptide of the novel zinc finger protein ZNF32 proved to be specific and sensitive for immunological measurements
por: Wei, Yuyan, et al.
Publicado: (2012)

Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
por: Rappazzo, C. Garrett, et al.
Publicado: (2021)

Potent Molecular Feature-based Neutralizing Monoclonal Antibodies as Promising Therapeutics Against SARS-CoV-2 Infection
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2021)

MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants
por: Lee, Sua, et al.
Publicado: (2021)

Encapsulation of ovarian allograft precludes immune rejection and promotes restoration of endocrine function in immune-competent ovariectomized mice
por: Day, James Ronald, et al.
Publicado: (2019)

TNFRSF13B polymorphisms counter microbial adaptation to enteric IgA
por: Platt, Jeffrey L., et al.
Publicado: (2021)

Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants
por: Chen, Zhaochun, et al.
Publicado: (2022)

Monoclonal antibody therapies against SARS-CoV-2
por: Focosi, Daniele, et al.
Publicado: (2022)

Potent neutralizing monoclonal antibodies against Ebola virus infection
por: Zhang, Qi, et al.
Publicado: (2016)

Regional delivery of immunosuppression for transplantation of vascularized composite allografts: opportunities near and far
por: Platt, Jeffrey L., et al.
Publicado: (2021)

Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
por: Yu, Fei, et al.
Publicado: (2020)

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody
por: Torres, Jonathan L., et al.
Publicado: (2022)

91074 Identification of monoclonal antibodies with broad reactivity against the malaria parasite variant surface antigen responsible for severe malaria
por: Reyes, Raphael, et al.
Publicado: (2021)

Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters
por: Piepenbrink, Michael S., et al.
Publicado: (2021)

Production and Characterization of Monoclonal Antibodies Against the Nucleocapsid Protein of SARS-COV
por: Fang, Ying, et al.
Publicado: (2006)

Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies
por: Terry, James S., et al.
Publicado: (2020)

A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine
por: Jangra, Sonia, et al.
Publicado: (2021)

Potent neutralizing RBD‐specific antibody cocktail against SARS‐CoV‐2 and its mutant
por: Jia, Lina, et al.
Publicado: (2021)

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2
por: Xie, Jiajia, et al.
Publicado: (2021)

Characterization of a new monoclonal anti-glypican-3 antibody specific to the hepatocellular carcinoma cell line, HepG2
por: Vongchan, Preeyanat, et al.
Publicado: (2017)

TNFRSF13B genotypes control immune-mediated pathology by regulating the functions of innate B cells
por: de Mattos Barbosa, Mayara Garcia, et al.
Publicado: (2021)

Novel monoclonal antibody against integrin α3 shows therapeutic potential for ovarian cancer
por: Ke, Feng‐Yi, et al.
Publicado: (2020)

Cell Fusion in the War on Cancer: A Perspective on the Inception of Malignancy
por: Platt, Jeffrey L., et al.
Publicado: (2016)

Therapeutic Administration of a Monoclonal Anti-Il-1β Antibody Protects Against Experimental Melioidosis
por: Weehuizen, Tassili A. F., et al.
Publicado: (2016)

Current status of therapeutic monoclonal antibodies against SARS-CoV-2
por: Kumar, Sanjeev, et al.
Publicado: (2021)

In-Silico Analysis of Monoclonal Antibodies against SARS-CoV-2 Omicron
por: Hu, Ye-Fan, et al.
Publicado: (2022)

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
por: Tian, Xiaolong, et al.
Publicado: (2020)

Potently neutralizing and protective human antibodies against SARS-CoV-2
por: Zost, Seth J., et al.
Publicado: (2020)

Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody
por: Terry, James S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_etojo4gbekan09907g8gveers4